SYROS PHARMACEUTICALS INC COM USD0.001 (POST REV SPLIT) earnings per share and revenue

0LC7 earnings per share for the last quarter are -0.16 USD whereas the estimation was -0.68 USD which accounts for 76.34% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 360.00 k USD. Estimated earnings per share for the next quarter are -0.69 USD, and revenue is expected to reach 450.00 k USD. Also watch annual changes over time to get a bigger picture of 0LC7 earnings per share and revenue dynamics.